Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors

Clinical trial NCT07714395 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07714395
Sponsor: Actuate Therapeutics Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2026-10-01
Primary completion: 2029-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.